Position in ELAN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$69,244,517
-$12,316,843 QoQ
Shares Held
2,813,674
-17.4% QoQ
Ownership
0.563%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#31
of 518 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Capital World Investors holds $493,965,382 across 2 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
12,536,035 | $424,720,865 | |
| 2 | ELAN |
Elanco Animal Health Inc
This page
|
2,813,674 | $69,244,517 |
All Filings in ELAN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,244,517 | 2,813,674 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $81,561,360 | 3,408,331 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $47,045,235 | 2,078,888 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $41,868,804 | 2,078,888 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $28,560,000 | 2,000,000 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||